|
BAT2L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.018100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.86040000000376E-05 |
| Normal-vs-Stage2 |
1.488490E-02 |
| Normal-vs-Stage3 |
2.058000E-02 |
| Normal-vs-Stage4 |
6.142400E-02 |
| Stage1-vs-Stage2 |
7.167000E-01 |
| Stage1-vs-Stage3 |
8.644000E-01 |
| Stage1-vs-Stage4 |
6.890000E-01 |
| Stage2-vs-Stage3 |
8.586200E-01 |
| Stage2-vs-Stage4 |
5.272400E-01 |
| Stage3-vs-Stage4 |
6.620400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.220300E-04 |
| Normal-vs-AfricanAmerican |
4.398500E-04 |
| Normal-vs-Asian |
1.85949999998991E-05 |
| Caucasian-vs-AfricanAmerican |
6.407000E-01 |
| Caucasian-vs-Asian |
7.308400E-02 |
| AfricanAmerican-vs-Asian |
4.087600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11559999999666E-05 |
| Normal-vs-Female |
1.724970E-01 |
| Male-vs-Female |
4.963700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.639520E-02 |
| Normal-vs-Extreme_Weight |
3.97859999999861E-05 |
| Normal-vs-Obese |
7.085800E-02 |
| Normal-vs-Extreme_Obese |
2.556800E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.987800E-01 |
| Normal_Weight-vs-Obese |
4.496200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.793400E-01 |
| Extreme_Weight-vs-Obese |
6.084400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.010800E-01 |
| Obese-vs-Extreme_Obese |
3.034400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.977760E-01 |
| Normal-vs-Age(41-60Yrs) |
4.762200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.85640000005538E-06 |
| Normal-vs-Age(81-100Yrs) |
1.141670E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.247200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.294200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.890800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.396400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.892430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.337400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.177190E-03 |
| Normal-VS-Type2 PRCC |
3.07010000000218E-06 |
| Normal-VS-KIRP CIMP |
9.909400E-01 |
| Normal-VS-Unclassified PRCC |
2.097200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.615600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.709580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.597800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.501900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.420400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.926600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.88859999755908E-08 |
| Normal-vs-N1 |
1.973410E-01 |
| Normal-vs-N2 |
9.807800E-01 |
| N0-vs-N1 |
7.921800E-02 |
| N0-vs-N2 |
2.273600E-02 |
| N1-vs-N2 |
5.985800E-01 |
|
|
